N-(3,4-Dimethoxyphenyl)-5-methyl-11-oxo-5H,5aH,6H,7H,8H,9H,11H-pyrido[2,1-b]quinazoline-3-carboxamide

Catalog No. :
ACDQOZ583
CAS No. :
1574591-11-9
Molecular Formula :
C22H25N3O4
Molecular Weight :
395.46

IUPAC Name:N-(3,4-dimethoxyphenyl)-5-methyl-11-oxo-5,5a,6,8,9,11-hexahydro-7H-pyrido[2,1-b]quinazoline-3-carboxamide

N-(3,4-Dimethoxyphenyl)-5-methyl-11-oxo-5H,5aH,6H,7H,8H,9H,11H-pyrido[2,1-b]quinazoline-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$321.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3,4-Dimethoxyphenyl)-5-methyl-11-oxo-5H,5aH,6H,7H,8H,9H,11H-pyrido[2,1-b]quinazoline-3-carboxamide
IUPAC NameN-(3,4-dimethoxyphenyl)-5-methyl-11-oxo-5,5a,6,8,9,11-hexahydro-7H-pyrido[2,1-b]quinazoline-3-carboxamide
MDL No.MFCD28506473
Molecular FormulaC22H25N3O4
Molecular Weight395.46
SMILESO=C(C1=CC(N(C)C2N3CCCC2)=C(C=C1)C3=O)NC4=CC=C(OC)C(OC)=C4
InChI KeyDFBBBAUEDCCQIB-UHFFFAOYSA-N
SynonymN-(3,4-dimethoxyphenyl)-5-methyl-11-oxo-5H,5aH,6H,7H,8H,9H,11H-pyrido[2,1-b]quinazoline-3-carboxamide;7H-Pyrido[2,1-b]quinazoline-3-carboxamide, N-(3,4-dimethoxyphenyl)-5,5a,6,8,9,11-hexahydro-5-methyl-11-oxo-
CAS No.1574591-11-9

Synthetic Route by SureRoute

1. ACDQOZ583 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOSMP860 route compound structure diagram
    ACOSMP8606315-89-5 In Stock
  4. Then
  5. ACDQOZ583 route product structure diagram
    ACDQOZ5831574591-11-9
Inquiry

2. ACDQOZ583 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOSMP860 route compound structure diagram
    ACOSMP8606315-89-5 In Stock
  4. Then
  5. ACDQOZ583 route product structure diagram
    ACDQOZ5831574591-11-9
Inquiry

Comments (0)